wakix
bioprojet pharma - pitolisant - narkolepsija - other nervous system drugs - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.
crysvita
kyowa kirin holdings b.v. - burosumabs - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - zāles kaulu slimību ārstēšanai - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.
paracetamol sopharma 500 mg tabletes
sopharma ad, bulgaria - paracetamols - tablete - 500 mg
bromhexin sopharma 8 mg tabletes
sopharma ad, bulgaria - bromheksīna hidrohlorīds - tablete - 8 mg
orlistat polpharma 60 mg cietās kapsulas
pharmaceutical works polpharma sa, poland - orlistats - kapsula, cietā - 60 mg
metoclopramid polpharma 10 mg/2 ml šķīdums injekcijām
pharmaceutical works polpharma sa, poland - metoklopramīda hidrohlorīds - Šķīdums injekcijām - 10 mg/2 ml
metoclopramid polpharma 10 mg tabletes
pharmaceutical works polpharma sa, poland - metoklopramīda hidrohlorīds - tablete - 10 mg
quetiapine polpharma 200 mg apvalkotās tabletes
zaklady farmaceutyczne polpharma s.a., poland - kvetiapīns - apvalkotā tablete - 200 mg
quetiapine polpharma 100 mg apvalkotās tabletes
zaklady farmaceutyczne polpharma s.a., poland - kvetiapīns - apvalkotā tablete - 100 mg
quetiapine polpharma 25 mg apvalkotās tabletes
zaklady farmaceutyczne polpharma s.a., poland - kvetiapīns - apvalkotā tablete - 25 mg